The Pharmaceuticals UltraSector ProFund seeks daily investment results, before fees and expenses, that are 1.5x the return of the Dow Jones U.S. Select Pharmaceuticals Index (the "Index") for a single day.
| Investor Class | Service Class | |
|---|---|---|
| Ticker | PHPIX | PHPSX |
| CUSIP | 743185423 | 743185415 |
| Fund Number | 047 | 077 |
| Inception Date | 6/28/2000 | |
| Fund Group | Sector ProFunds - UltraSector | |
| Limits On Exchanges | None |
| Minimum Investment | |
| Individual Investor | $15,000 |
| Financial Professionals | $5,000 |
| Class | NAV | % Change | $ Change | |
|---|---|---|---|---|
| Investor | $24.38 | 0.95% | $0.23 | NAV History |
| Service | $21.08 | 0.96% | $0.20 | NAV History |
Chart data provided by Thomson Reuters. |
||||
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the original cost.
For standardized returns year-to-date, and as of the most recent calendar quarter-end, and annualized month-end, see performance. Returns include the reinvestment of dividends and capital gains.
| YTD (as of 1/28/2020) | 0.99% |
| Average Annual One Year | 19.98% |
| Average Annual Three Year | 5.50% |
| Average Annual Five Year | 3.08% |
| Average Annual Ten Year | 12.94% |
| Average Annual Since Inception | 2.26% |
| Cumulative Since Inception | 54.75% |
| Gross Expense Ratio | 1.78% |
| Net Expense Ratio * | 1.78% |
* Contractual waiver effective from December 1, 2018 through November 30, 2019. Without such a waiver of fees, the total returns may have been lower.
All data, unless otherwise noted, is as of 12/31/2019 and for Investor Class Shares only and is subject to change.
The Index (Bloomberg Ticker: DJSPHM) measures the performance of the pharmaceuticals sector of the U.S. equity market. Component companies include, among others, manufacturers of prescription or over-the-counter drugs. The Index includes vaccine producers, but excludes vitamin producers. It is not possible to invest directly in an index.
| Total Index Companies | 45 |
| Price/Earnings Ratio | 117.31 |
| Price/Book Ratio | 3.83 |
| Dividend Yield | 1.64% |
| Average Index Market Capitalization | 29.61 billion |
| Index Sector Weightings | Weight |
|---|---|
| Pharmaceuticals | 97.05% |
| Biotechnology | 2.95% |
| Top 10 Index Companies | Weight |
|---|---|
| Johnson & Johnson | 22.27% |
| Merck & Co. Inc. | 19.24% |
| Eli Lilly & Co. | 4.68% |
| Zoetis Inc. | 4.61% |
| Bristol-Myers Squibb Co. | 4.43% |
| Pfizer Inc. | 4.41% |
| Allergan PLC | 4.41% |
| Elanco Animal Health Inc. | 4.32% |
| Mylan NV | 4.08% |
| Jazz Pharmaceuticals PLC | 3.32% |